AKAli Al Khalifah

Ali Al Khalifah

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Ali Al Khalifah has a total of 6 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Adult Ileocolic Intussusception in a Patient With Cystic Fibrosis: Diagnostic Role of Point‐of‐Care Ultrasound ‘Case Report’

    by Ali Al Khalifah, Ali Aldawood

    Background: Cystic fibrosis (CF) is a multi‐system autosomal recessive disorder affecting the respiratory, gastrointestinal and reproductive systems. One of its manifestations is pancreatic insufficiency. This could lead to constipation and impaired intestinal activity predisposing patients to intestinal obstruction and intussusception. Key Findings: This report discusses a case of a 25‐year‐old male with CF who presented with abdominal pain and constipation. Point‐of‐care ultrasound (POCUS) was instrumental in the early diagnosis of intussusception, showing the classical sonographic features of intussusception. Discussion: This case highlights the importance of clinical vigilance and the utility of POCUS when managing patients with multi‐systemic diseases, as they may present with atypical symptoms and rare diagnoses. Ultrasound is highly sensitive for diagnosing intussusception in the paediatric populations, but further studies may be needed to translate that finding to the adult population. Complementary computed tomography (CT) is of high value in evaluating for possible complications.

  • Open Access

    Predictors of Intensive Care Admission Among Adult Patients with Sickle Cell Disease in Eastern Province of Saudi Arabia

    by Mortadah Alsalman, Zaenb Alsalman, Hussain Abduljaleel Alkhalifa, Aman N Alfaraj, Ali Alkhalifah, Qasem Almulihi

    Purpose: Sickle cell disease (SCD) comprises a complex group of hematologic disorders that are collectively the most common monogenic disorder and are associated with increased risk of intensive care unit admission (ICU). The purpose of this study is to investigate factors that predict admission of adult patients with SCD to the ICU. Patients and Methods: This was a cross-sectional study that enrolled adult patients with SCD from Saudi Arabia. Results: A total of 107 patients with SCD, with a median age 31.9± 12.1 years, were evaluated retrospectively. Regarding predictors of ICU admission, patients who indicated a history of blood transfusions were at 8.047-fold higher risk of ICU admission (OR=8.047; 95% CI=2.392– 27.07; p=0.001). Patients who started hydroxyurea were at least 3.071 times more likely to be admitted than those who did not (OR=3.071; 95% CI=1.164– 8.104; p=0.023). We also observed three or more hospitalizations per year to be associated with increased risk of ICU admission (OR=3.393; 95% CI=1.285– 8.960; p=0.014), with those making 3 to 5 visits annually having at least 10.4 times higher risk (OR=10.38; 95% CI=10.098– 98.19; p=0.041) and those with 6 to 10 ER admissions having 18 times higher risk (OR=18.00; 95% CI=2.149– 150.8; p=0.008). Finally, patients with high WBC were predicted to have at least 3.34 times higher risk of ICU admission (OR=3.337; 95% CI=1.131– 9.846; p=0.029). Conclusion: SCD is a multi-systemic disease associated with increased morbidity and mortality. Recognition of high-risk features in patients helps to eliminate subjectivity in ICU referral decision. Frequent hospitalization and emergency visits, multiple blood transfusions, and elevated white blood cell count were significantly associated with a higher rate of ICU admission despite hydroxyurea usage.